Dr. James Thomas Dean III, DO

Dr. Dean practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Dean's NPI, 1891181491, was assigned on April 9, 2015. Dr. Dean holds New Mexico license A-2139-18.

Dr. Dean's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Dean's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Dean to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Dean is licensed in New Mexico.

CMS data shows 254 Medicare services from Dr. Dean across 10 procedure codes in 2024, for 156 Medicare patients. Medicare paid $21,252 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Dean in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 55% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 54, with 46% women.

In 2024, Dr. Dean wrote 239 Medicare Part D claims for 66 patients. 51% of them were for generic drugs. CMS names the drug for 148 of them, across 7 drugs with 11 or more claims each, at $35,571 in total drug cost. In 2023, CMS named 133 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Dean for performance year 2024, reported as part of a group. Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Dean, published from 2023 to 2024. 2024 was the busiest year, with 2. Dr. Dean's most frequent co-authors are Nathan Dean Nielsen, MD, Pablo Garcia, MD and Adam Laertes Gottula.

CMS Open Payments shows 3 general payments to Dr. Dean from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 81% of the total. United Therapeutics Corporation paid the most, $113.